GeraWitness in Nigeria 2026 — Human-in-the-loop agent safety for Nigerian fintech, health and logistics
Published 21 April 2026 · 9 min read
Quick answer: GeraWitness is the human-review layer for AI-agent decisions in high-stakes Nigerian contexts — CBN-regulated fintech actions, MDCN-regulated clinical suggestions, NAICOM-regulated claim triage. Escalation queues with Nigerian-time-zone human reviewers, audit logs compliant with NDPA, and billing in naira via Paystack, Flutterwave, Opay or bank transfer.
Why Nigerian operators need human-in-the-loop
A payment agent that moves naira, a clinical agent that suggests prescriptions, a claims agent that adjudicates motor-insurance payouts — all have Nigerian regulatory counterparties (CBN, MDCN, NAICOM). None of them are ready for unreviewed autonomous agent decisions. GeraWitness is the escalation and review layer that makes agent deployments safe to operate today.
Regulatory anchor
CBN for fintech (AML, transaction monitoring), MDCN for clinical decisions, NAICOM for insurance, NDPC/NITDA for data and AI. Our workflow templates map agent decisions to the reviewer qualifications each regulator implicitly or explicitly expects.
Pricing in naira
Per-reviewed-decision pricing. Fintech escalations ₦120/decision. Clinical escalations ₦250/decision. Insurance claim triage ₦80/decision. Volume discounts above 10,000/month. Prices via useCountry().
Payments
Paystack, Flutterwave, Opay, Palmpay, Visa/Mastercard/Verve, bank transfer via NIBSS.
Reviewer network
Reviewers based in Lagos, Abuja, Port Harcourt, Ibadan and Benin City, covering Nigerian business hours and overlap with UK/EU hours for diaspora-serving operators.
How we compare
International HITL platforms (Scale AI, Surge, Invisible) operate mostly on US labour; they are not tuned for Nigerian regulator expectations. We are.
Related reading
Pidgin-English version of this guide is on the roadmap — tell us if you want it sooner.
Deploy agents safely in Nigeria
CBN/MDCN/NAICOM-aligned reviewers. Nigerian-hours coverage.
Request review